UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000016790
Receipt No. R000019489
Scientific Title A Phase I study of intratumoral administration of TDM-812 in patients with treatment-resistant breast cancer (RPN2siRNA)
Date of disclosure of the study information 2015/03/13
Last modified on 2018/03/30 16:50:20

No. Disposal Last modified on Item of update
1 Insert 2015/03/13 10:08:26
2 Update 2015/03/18 14:14:57 UMIN ID1
3 Update 2015/03/18 14:15:40 Recruitment status
4 Update 2017/03/13 10:33:59 Last follow-up date
5 Update 2017/09/14 16:02:27 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2017/09/21 10:49:36 Recruitment status
7 Update 2018/03/30 16:50:20 Recruitment status

Contact us.